
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
T cell receptor mimic antibodies for cancer therapy
Leonid Dubrovsky, Tao Dao, Ron S. Gejman, et al.
OncoImmunology (2015) Vol. 5, Iss. 1, pp. e1049803-e1049803
Open Access | Times Cited: 38
Leonid Dubrovsky, Tao Dao, Ron S. Gejman, et al.
OncoImmunology (2015) Vol. 5, Iss. 1, pp. e1049803-e1049803
Open Access | Times Cited: 38
Showing 26-50 of 38 citing articles:
Monoclonal Antibodies in Dermatooncology—State of the Art and Future Perspectives
Małgorzata Bobrowicz, Radosław Zagożdżon, J Domagała, et al.
Cancers (2019) Vol. 11, Iss. 10, pp. 1420-1420
Open Access | Times Cited: 15
Małgorzata Bobrowicz, Radosław Zagożdżon, J Domagała, et al.
Cancers (2019) Vol. 11, Iss. 10, pp. 1420-1420
Open Access | Times Cited: 15
Proteolysis-Targeting Chimeras Enhance T Cell Bispecific Antibody-Driven T Cell Activation and Effector Function through Increased MHC Class I Antigen Presentation in Cancer Cells
Vittoria Massafra, Sofia Tundo, Aline Dietzig, et al.
The Journal of Immunology (2021) Vol. 207, Iss. 2, pp. 493-504
Open Access | Times Cited: 11
Vittoria Massafra, Sofia Tundo, Aline Dietzig, et al.
The Journal of Immunology (2021) Vol. 207, Iss. 2, pp. 493-504
Open Access | Times Cited: 11
Molecular basis for antibody recognition of multiple drug–peptide/MHC complexes
Lorenzo Maso, Epsa Rajak, Injin Bang, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 22
Open Access | Times Cited: 1
Lorenzo Maso, Epsa Rajak, Injin Bang, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 22
Open Access | Times Cited: 1
Conformation-selective rather than avidity-based binding to tumor associated antigen derived peptide-MHC enables targeting of WT1-pMHC low expressing cancer cells by anti-WT1-pMHC/CD3 T cell engagers
Even Walseng, Bo Wang, Chunning Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Even Walseng, Bo Wang, Chunning Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Comparative analysis of the CDR loops of antigen receptors
Wing Ki Wong, Jinwoo Leem, Charlotte M. Deane
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 6
Wing Ki Wong, Jinwoo Leem, Charlotte M. Deane
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 6
Extensive functional comparisons between chimeric antigen receptors and T cell receptors highlight fundamental similarities
Xueyin Wang, Aaron D. Martin, Kathleen R. Negri, et al.
Molecular Immunology (2021) Vol. 138, pp. 137-149
Open Access | Times Cited: 6
Xueyin Wang, Aaron D. Martin, Kathleen R. Negri, et al.
Molecular Immunology (2021) Vol. 138, pp. 137-149
Open Access | Times Cited: 6
Mechanisms of leukemia resistance to antibody dependent cellular cytotoxicity
Leonid Dubrovsky, Elliott J. Brea, Dmitry Pankov, et al.
OncoImmunology (2016) Vol. 5, Iss. 9, pp. e1211221-e1211221
Open Access | Times Cited: 5
Leonid Dubrovsky, Elliott J. Brea, Dmitry Pankov, et al.
OncoImmunology (2016) Vol. 5, Iss. 9, pp. e1211221-e1211221
Open Access | Times Cited: 5
Low-Dose CDK4/6 Inhibitors Induce Presentation of Pathway Specific MHC ligands as Targets for Cancer Immunotherapy
Angel Charles, Christopher M. Bourne, Zita E. H. Aretz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 5
Angel Charles, Christopher M. Bourne, Zita E. H. Aretz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 5
The potential applications of T cell receptor (TCR)-like antibody in cervical cancer immunotherapy
Sylvia Annabel Dass, Rehasri Selva Rajan, Gee Jun Tye, et al.
Human Vaccines & Immunotherapeutics (2021) Vol. 17, Iss. 9, pp. 2981-2994
Open Access | Times Cited: 5
Sylvia Annabel Dass, Rehasri Selva Rajan, Gee Jun Tye, et al.
Human Vaccines & Immunotherapeutics (2021) Vol. 17, Iss. 9, pp. 2981-2994
Open Access | Times Cited: 5
Potent antitumor activity of a bispecific T-cell engager antibody targeting the intracellular antigen KRAS G12V
Changchang Lu, Lu Zou, Qiaoli Wang, et al.
Biomolecules and Biomedicine (2024) Vol. 24, Iss. 5, pp. 1424-1434
Open Access
Changchang Lu, Lu Zou, Qiaoli Wang, et al.
Biomolecules and Biomedicine (2024) Vol. 24, Iss. 5, pp. 1424-1434
Open Access
DNA self-assembly-mediated high drug-antibody ratio ADC platform for targeted tumor therapy and imaging
Shijie Jin, Xinlei Zhuang, Yingchun Xu, et al.
Nano Today (2024) Vol. 58, pp. 102459-102459
Open Access
Shijie Jin, Xinlei Zhuang, Yingchun Xu, et al.
Nano Today (2024) Vol. 58, pp. 102459-102459
Open Access
De novodesign and structure of a peptide-centric TCR mimic binding module
Karsten D. Householder, Xinyu Xiang, Kevin M. Jude, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Karsten D. Householder, Xinyu Xiang, Kevin M. Jude, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
CAR-J cells for antibody discovery and lead optimization of TCR-like immunoglobulins
Christian Jöst, Diana Darowski, John Challier, et al.
mAbs (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Christian Jöst, Diana Darowski, John Challier, et al.
mAbs (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 3